The essence of the OSUCCC resides in its 6 Research Programs and 18 Shared Resources. It is composed of 179 full members, 38 associate and 24 introductory associate members from 13 of the 18 University colleges. Its clinical facilities include the freestanding James Cancer Hospital (JCH) as well as Nationwide Children's Hospital and now OSU East Hospital where cancer care is provided to inner city residents. To coordinate and manage an organization of this magnitude, the University supports the position of a strong CCC Director, who reports directly to the chief academic officer of the University, the Executive Vice President and Provost. Organizational capabilities of the CCC have been considerably strengthened by President Gee's appointment of Dr. Caligiuri as CEO of The James Cancer Hospital;his reporting to the President of the University, as well as his new membership on the President's Cabinet, and his continued membership on the Medical Center Executive Committee. In this capacity, Dr. Caligiuri privately meets at least monthly with President Gee, twice monthly with Provost Alutto, and at least weekly with Sr. VP Gabbe. This ensures that the Cancer Program's oversight planning and evaluation are in place and integrated within the University's strategic initiatives. These meetings assure cancer representation in the major initiatives across the University and the health system, and keep the President, Provost and Sr. VP adequately advised of all activity within the OSUCCC, including The JCH. In a large and diverse university, this organizational structure allows the Director to take maximum advantage of OSU's strengths and capabilities in promoting the cancer program agenda.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016058-38
Application #
8601800
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-12-01
Budget End
2014-11-30
Support Year
38
Fiscal Year
2014
Total Cost
$39,608
Indirect Cost
$13,636
Name
Ohio State University
Department
Type
DUNS #
832127323
City
Columbus
State
OH
Country
United States
Zip Code
43210
Sizemore, Gina M; Balakrishnan, Subhasree; Thies, Katie A et al. (2018) Stromal PTEN determines mammary epithelial response to radiotherapy. Nat Commun 9:2783
Zeng, Rong; Liu, Yi; Jiang, Zhao-Jing et al. (2018) EPB41L3 is a potential tumor suppressor gene and prognostic indicator in esophageal squamous cell carcinoma. Int J Oncol :
Kotlarek, Marta; Kubiak, Anna; Czetwerty?ska, Ma?gorzata et al. (2018) The rs2910164 Genetic Variant of miR-146a-3p Is Associated with Increased Overall Mortality in Patients with Follicular Variant Papillary Thyroid Carcinoma. Int J Mol Sci 19:
Li, Feng; Malli, Ahmad; Cruz-Monserrate, Zobeida et al. (2018) Confocal endomicroscopy and cyst fluid molecular analysis: Comprehensive evaluation of pancreatic cysts. World J Gastrointest Endosc 10:1-9
He, Huiling; Li, Wei; Yan, Pearlly et al. (2018) Identification of a Recurrent LMO7-BRAF Fusion in Papillary Thyroid Carcinoma. Thyroid 28:748-754
Moshiri, Jasmine; Kaur, Darpan; Hambira, Chido M et al. (2018) Identification of a Small Molecule Anti-biofilm Agent Against Salmonella enterica. Front Microbiol 9:2804
Serna, Vanida A; Wu, Xin; Qiang, Wenan et al. (2018) Cellular kinetics of MED12-mutant uterine leiomyoma growth and regression in vivo. Endocr Relat Cancer 25:747-759
Dabrowski, Konrad; Miller, Mackenzie (2018) Contested Paradigm in Raising Zebrafish (Danio rerio). Zebrafish 15:295-309
Krok-Schoen, Jessica L; Fisher, James L; Baltic, Ryan D et al. (2018) White-Black Differences in Cancer Incidence, Stage at Diagnosis, and Survival Among Older Adults. J Aging Health 30:863-881
Killian, Jackson A; Topiwala, Taha M; Pelletier, Alex R et al. (2018) FuSpot: a web-based tool for visual evaluation of fusion candidates. BMC Genomics 19:139

Showing the most recent 10 out of 2602 publications